Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
New England Journal of Medicine2023Vol. 389(14), pp. 1286–1297
Citations Over TimeTop 1% of 2023 papers
Hölger Thiele, Uwe Zeymer, İbrahim Akın, Michael Behnes, Tienush Rassaf, Amir A. Mahabadi, Ralf Lehmann, Ingo Eitel, Tobias Graf, Tim Seidler, Andreas Schuster, Carsten Skurk, Daniel Duerschmied, Peter Clemmensen, Marcus Hennersdorf, Stephan Fichtlscherer, Ingo Voigt, Melchior Seyfarth, Stefan John, Sebastian Ewen, Axel Linke, Eike Tigges, Peter Nordbeck, Leonhard Bruch, Christian Jung, Jutta Franz, Philipp Lauten, Tomaž Goslar, Hans‐Josef Feistritzer, Janine Pöss, Eva Kirchhof, Taoufik Ouarrak, Steffen Schneider, Steffen Desch, Anne Freund
Abstract
In patients with acute myocardial infarction complicated by cardiogenic shock with planned early revascularization, the risk of death from any cause at the 30-day follow-up was not lower among the patients who received ECLS therapy than among those who received medical therapy alone. (Funded by the Else Kröner Fresenius Foundation and others; ECLS-SHOCK ClinicalTrials.gov number, NCT03637205.).
Related Papers
- → Extracorporeal Life Support Organization Registry International Report 2016(2016)899 cited
- → Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experience*(2009)101 cited
- → Extracorporal life support for pulmonary hemorrhage in children: A case series(2002)65 cited
- → Extracorporeal life support for the neonatal cardiac patient: Outcomes and new directions(2014)22 cited
- Advances in Research of Cardiogenic Shock After Acute Myocardial Infarction(2005)